Genuity Science is a wholly-owned subsidiary of US biotechnology company, HiberCell. Genuity Science is using world-leading genomics and machine learning to map the causal biology of disease and accelerate the development of better medicine. Our unique hybrid platform enables us and our partners to go from data to insights to impact with unrivaled power and efficiency, generating, validating and applying insights on virtually any disease to create novel drugs, diagnostics and tools for clinical care. Our capabilities span deeply phenotyped population genomics cohorts, CAP-accredited sequencing and comprehensive omics, world-renowned bioinformatics, and pioneering, validated and peer-reviewed AI/ML. Through our offices in Boston, Dublin and Reykjavik we put this platform to work for our global biopharma and life sciences partners and the patients they serve. To learn more, visit us at www.genuitysci.com.
Location: United States, Massachusetts, Boston
Employees: 51-200
Phone: +1 617-250-3500
Founded date: 2013
Investors 1
| Date | Name | Website |
| 08.11.2023 | ARCH Ventu... | archventur... |
Mentions in press and media 4
| Date | Title | Description |
| 28.06.2021 | Accelerating Lupus Drug Discovery & Development: Fireside Chat with Experts in SLE Research, Upcoming Webinar Hosted by Xtalks | Register for this webinar hear an examination of why researching lupus is so complex and the fundamental challenges of SLE research. TORONTO, Ontario (PRWEB) June 28, 2021 Genuity Science is bringing together a distinguished panel of expert... |
| 01.04.2021 | Genomic Validation of Novel Therapeutic Targets in Neurodegeneration, Upcoming Webinar Hosted by Xtalks | While several monogenetic variants contribute to familial heritability of Alzheimer’s and Parkinson’s diseases, the more common sporadic forms of these diseases are likely the result of many susceptibility loci. TORONTO (PRWEB) April 01, 20... |
| 02.02.2021 | Genomic Advances in Heart Failure, Upcoming Webinar Hosted by Xtalks | The speakers will discuss what is currently known about genomic drivers of heart failure and opportunities for novel therapeutics being explored in their own research programs. TORONTO (PRWEB) February 02, 2021 Heart failure is a significan... |
| 23.06.2020 | Meet the latest genomic data company — aka WuXi NextCODE without the China operations | Just five years after WuXi engineered a deal to merge its genome center with NextCODE Health, the WuXi NextCODE brand is becoming history as the company cuts off the Chinese operations and focuses on the US, Iceland and Ire... |